Experts Matter. Find Yours.

Childhood psychology expert on migrant children at U.S.-Mexico border

Kathryn Humphreys, assistant professor, department of psychology and human development, is available for commentary on the influx of migrant children at the border and group-based housing for these children. Kathryn received her doctoral degree in clinical psychology and has expertise in infant and early childhood mental health. Her research focuses on characterizing the early environment and examining links to later life outcomes.  Some of her recent research finds that stressful or traumatic experiences occurring in a child’s earliest years—birth to age 5—have been linked to reduced hippocampal volume in adolescence, which is connected to learning, memory and mood.

How well do you know your sense of touch? UMW’s Sushma Subramanian explains it all in new book

The University of Mary Washington’s Sushma Subramanian’s latest book, How to Feel: The Science and Meaning of Touch, is now available on bookstore shelves and online retailers across America. The journalist, assistant professor and author was recently featured in Discover Magazine, where she shares her inspiration for the book and sits down to answer to serious questions about science and the need to touch. Several years ago, Sushma Subramanian was procrastinating on her work when she noticed her desk was a bit wobbly. It was a rather mundane moment, she recalls, and one that’s only a vague memory now. But as she began to fiddle with the shaky tabletop, the science journalist found herself noting how the experience felt: the grain of the wood against her fingers, the pinching of her skin and the sensation of her muscles straining to lift the desk. As Subramanian explains in her book, How to Feel: The Science and Meaning of Touch, it was a moment when she began to consider how little she knew about this multifaceted sense — “a capacity,” she writes, “that never shuts off.” The questions kept forming, eventually leading Subramanian, a professor of journalism at the University of Mary Washington, to write an article for Discover in 2015 about the development of tactile touch screens — which use haptic technology, such as vibrations in handheld devices. In her latest work, she dives deeper into that world, but also explores the limits of our sense of touch and what makes it so versatile. Discover caught up with Subramanian to talk about touch in the age of COVID-19, the future of tactile research and how we experience the sense differently across personal and cultural barriers. March 08 - Discover Magazine Her interview is also part of the attached article and is a very compelling read. If you are a journalist looking to speak with Sushma Subramanian about her latest book, then let us help. Simply click on Sushma’s icon now to arrange a time and interview.

Ask the Expert: Vaccine myths and scientific facts

Now that there are authorized and recommended COVID-19 vaccines, it is critical people receive accurate information. Peter Gulick, professor of medicine at the Michigan State University College of Osteopathic Medicine and infectious disease expert, reviews some myths about the vaccine and counters these with scientific facts. Myth: The COVID-19 vaccines were developed in a rush, so their effectiveness and safety can’t be trusted. Fact: Studies found that the Pfizer/BioNTech and Moderna are both about 95% effective compared to the influenza vaccine, which ranges from being 50% to 60% effective each year. The Johnson & Johnson vaccine is 85% effective at curbing serious or moderate illness. The most important statistic is that all three were 100% effective in stopping hospitalizations and death. As of March 9, 2021, the Centers for Disease Control and Prevention reports that 93.7 million people have been vaccinated and all safety data collected from these doses show no red flags. There have been about 5 cases of anaphylaxis, an allergic reaction, per 1 million but this is no different than allergic reactions from other vaccines. There are many reasons why the COVID-19 vaccines could be developed so quickly and here are a few: The COVID-19 vaccines from Pfizer/BioNTech and Moderna were created with a messenger RNA technology that has been in development for years, so the companies could start the vaccine development process early in the pandemic. China isolated and shared genetic information about COVID-19 promptly so scientists could start working on vaccines. The vaccine developers didn’t skip any testing steps but conducted some of the steps on an overlapping schedule to gather data faster. The Pfizer/BioNTech and Moderna vaccines were created using messenger RNA, or mRNA, which allows a faster approach than the traditional way that vaccines are made. Because COVID-19 is so contagious and widespread, it did not take long to see if the vaccine worked for the vaccinated study volunteers. Companies began making vaccines early in the process — even before FDA authorization — so some supplies were ready when authorization occurred. They develop COVID-19 vaccines so quickly also due to years of previous research on the SARS COV-1, a related virus. Myth: The messenger RNA technology used to make the Pfizer/BioNTech and Moderna COVID-19 vaccine is brand new. Fact: The messenger RNA technology behind these two vaccines has been studied and in development for almost two decades. Interest has grown in these vaccines because they can be developed in a laboratory using readily available materials, making vaccine development faster. mRNA vaccines have been studied before for flu, Zika and rabies. Myth: You only need one dose of J&J vaccine so it’s more effective. Fact: Johnson & Johnson’s vaccine uses a different strategy — a weakened cold virus that is reprogrammed to include the code for the spike protein. Once inside the body, the viral genes trigger a similar response against the virus. All three vaccines are considered overall effective and 100% effective in preventing hospitalizations and death. Myth: Vaccine efficacy and effectiveness mean the same thing. Fact: Efficacy and effectiveness do not mean the same thing. “Efficacy” refers to the results for how well a drug or vaccine works based on testing while “effectiveness” refers to how well these products work in the real world, in a much larger group of people. Most people, however, use them interchangeably even though they have different scientific meanings. Myth: The vaccines aren’t effective against new strains of the virus. Fact: Currently, we know both the U.K. strain as well as the South African variant have increased transmissibility of 30% to 50% over the natural strain. As far as an increase in causing more serious disease, it is not known yet. We have over 600 U.K. variants in Michigan and one case of the South African variant, and I just heard of 47 cases of the U.K. variant in Grand Ledge. We (Michigan) are second in the nation in variants, but that's likely because we test for them more. The most important information is that the vaccines, in general, are 100% effective in prevention of hospitalization and death. So, it is felt they all offer some protection against variants to prevent serious disease. As far as the Johnson & Johnson, it was used with variants and has efficacy overall of 72% in U.S., 66% in Latin America and 57% in South Africa (where the main strain is the South African variant). All companies are looking at modifying (their products) (the mRNA) to cover variants and either give a booster or a multivalent vaccine to cover all variants. Myth: There are severe side effects of the COVID-19 vaccines. Fact: The COVID-19 vaccine can have side effects, but the vast majority go away quickly and aren’t serious. The vaccine developers report that some people experience pain where they were injected; body aches; headaches or fever, lasting for a day or two. This is good and are signs that the vaccine is working to stimulate your immune system. If symptoms persist beyond two days, you should call your doctor. Myth: Getting the COVID-19 vaccine gives you COVID-19. Fact: The vaccine for COVID-19 cannot and will not give you COVID-19. The two authorized mRNA vaccines instruct your cells to reproduce a protein that is part of the SARS-CoV-2 coronavirus, which helps your body recognize and fight the virus, if it comes along. The COVID-19 vaccine does not contain the SARS-Co-2 virus, so you cannot get COVID-19 from the vaccine. The Johnson & Johnson vaccine was developed using adenovirus vector technology and also will not give you COVID-19. It shows your immune system a weakened, common cold virus “disguised” as the coronavirus instead. Adenovirus vaccines have been around for about two decades, the same as mRNA vaccines. Johnson & Johnson developed a vaccine for Ebola using this technology. Myth: The vaccines are ineffective against the virus variants. Fact: More time is needed to study the vaccines’ effectiveness against the variants. Studies are now being conducted to determine if a booster dose is needed to protect against the variants or if modifications to the vaccines are needed. Myth: I already had COVID-19 and I have recovered, so I don't need to get the vaccine. Fact: There is not enough information currently available to say if or for how long after getting COVID-19 someone is protected from getting it again. This is called natural immunity. Early evidence suggests natural immunity from COVID-19 may not last very long, but more studies are needed to better understand this. The CDC recommends getting the COVID-19 vaccine, even if you’ve had COVID-19 previously. However, those that had COVID-19 should delay getting the vaccination until about 90 days from diagnosis. People should not get vaccinated if in quarantine after exposure or if they have COVID-19 symptoms. Myth: I won't need to wear a mask after I get the vaccine. Fact: It may take time for everyone who wants a COVID-19 vaccination to get one. Also, while the vaccine may prevent you from getting sick, more research is needed, but early indications show that while the vaccine is effective in reducing transmission, it is possible for a vaccinated person to spread the virus. Until more is understood about how well the vaccine works, continuing with precautions such as mask-wearing and physical distancing will be important. Myth: COVID-19 vaccines will alter my DNA. Fact: The COVID-19 vaccines will not alter any human genome and cannot make any changes to your DNA. The vaccines contain all the instructions necessary to teach your cells to make SARS-CoV-2's signature spike protein, release it out into the body, and your immune system gets a practice round at fighting off COVID-19. Myth: The COVID-19 vaccine can affect women’s fertility Fact: There is currently no evidence that antibodies formed from COVID-19 vaccination cause any problems with pregnancy, including the development of the placenta. In addition, there is no evidence suggesting that fertility problems are a side effect of any vaccine. People who are trying to become pregnant now or who plan to try in the future may receive the COVID-19 vaccine when it becomes available to them but it’s always prudent to consult with your doctor. Myth: The COVID-19 vaccine was developed to control the general population either through microchip tracking or "nanotransducers" in our brains. Fact: There is no vaccine microchip, and the vaccine cannot track people or gather personal information into a database. Myth: The vaccines were developed and produced using fetal tissue. Fact: The vaccines do not contain fetal cells nor were fetal cells used in the production the Pfizer and Moderna vaccines. Johnson & Johnson used human cell lines or also known as cell cultures to grow the harmless adenovirus but did not use fetal tissue. These same cell lines have been used for other vaccines including hepatitis, chickenpox and rabies and have been around for years. Peter Gulick is an associate professor of medicine at Michigan State University, College of Osteopathic Medicine, and serves as adjunct faculty in the College of Human Medicine and the College of Nursing. Dr. Gulick is available to speak with media - simply click on his icon now to arrange an interview today. Peter Gulick is an associate professor of medicine at Michigan State University, College of Osteopathic Medicine, and serves as adjunct faculty in the College of Human Medicine and the College of Nursing. Dr. Gulick is available to speak with media - simply click on his icon now to arrange an interview today.

What We Can Learn From Celebrating Irish-American Heritage Month

About two weeks ago, President Joseph Biden declared March 2021 Irish-American Heritage Month. In an official statement, the president said, "We owe a debt of gratitude to the Irish-American inventors and entrepreneurs who helped define America as the land of opportunity... The fabric of modern America is woven through with the green of the Emerald Isle." As the director of the Center for Irish Studies at Villanova University, an institution founded by Irish Augustinians to educate the children of Irish immigrants, Joseph Lennon, PhD, agrees. He hopes to use this presidential declaration as an opportunity to expand the conversation around what it means to be of Irish descent beyond wearing green and watching the annual St. Patrick's Day parade. The way Dr. Lennon sees it, "there is much more to Irish America than a parade and parties." With such a rich history of Irish immigrants and their descendants living in and contributing to the development of the United States, Dr. Lennon sees March 2021 as an important time to reflect on the "contributions and travails of this ethnicity" in a way that reaches beyond "silly slogans and marketing schemes." He reminds us, "there are over 30 million Irish Americans. The Irish contributed massively to the infrastructure of industrial America and later to the civil, education and business worlds—not to mention the Catholic Church." Dr. Lennon also hopes this month will help redefine the larger notion of what it looks like to be Irish and American. He notes that "38% of African Americans have Irish ancestry," but acknowledges that "this is a complicated issue," since in some cases this may stem from abuses suffered during the American practice of slavery. It is important conversations like these that Dr. Lennon wants to bring to light during Irish-American Heritage Month, and he stresses that "more research is needed into understanding this history—as well as the unions between Irish immigrants and northern-bound African Americans during the late nineteenth century." Per Dr. Lennon, these historical events are tied to our present day. He sees a need for "the level of recent racist attachments to Irishness... to be confronted with historical knowledge and anti-racist understandings." With such important issues in mind, Dr. Lennon wants to impart that "the Irish diaspora is global and diverse and Irish culture runs much more deeply and broadly in America than we might guess by just attending the St. Patrick's Day celebrations." He adds, "I'm curious to see if the conversation continues past St. Patrick's Day this year." Despite most St. Patrick’s Day events and programs being virtual in 2021, there are many opportunities to celebrate Irish-American heritage this year. At Villanova, the Center for Irish Studies is hosting a virtual St. Patrick's Day Celebration called "Links Across the Atlantic" on Wednesday, March 17, from 10:00 a.m. to 9:00 p.m. This free celebration will include live entertainment segments, from an Irish breakfast tutorial with study abroad director Mary Madec to lunchtime laughs with actor Johnny Murphy, and will culminate with a streamed Irish music fèis (or festival) in partnership with Tune Supply, featuring We Banjo 3, the Friel Sisters and One for the Foxes! For more information or to register for this event, please click here.

Ask an Expert: What is COVID-19’s impact on the homelessness crisis?

The COVID-19 pandemic continues to impact the homeless community and homelessness crisis, including posing unique health risks to the homeless population and spurring a likely increase in homelessness due to job losses. “People experiencing homelessness are at enormous risk of exposure to the coronavirus, due to inability to self-isolate, as evidenced by outbreaks in congregate shelters,” says Marybeth Shinn, Cornelius Vanderbilt Chair and professor of human, organizational and community development at Vanderbilt Peabody College of education and human development. “With the cold weather coming, service providers are scrambling to provide food, shelter and outreach services safely, and to use rental assistance to get people into housing.” Shinn also explains that while eviction moratoriums imposed during the pandemic work to delay evictions, they do not prevent them. Arrears for rent, utilities and fees continue to accumulate when the moratorium ends, and landlords can continue to charge late fees for late payments. On the one hand, moratoriums will help keep many renters in their homes at a time when the alternatives, such as crowding in with friends and relatives or even becoming homeless, puts people’s health at risk. At the same time, landlords, especially small landlords, are also suffering. Landlords often have mortgages as well as other expenses to pay, relying on rental income to do so. In her new book with Abt Associates researcher Jill Khadduri, In the Midst of Plenty: Homelessness and What to Do About It, Shinn argues that homelessness is not a result of personal failure, but rather societal failure, as we have the knowledge and resources to end homelessness but lack the political will. As an immediate step during the pandemic, Shinn advises that Congress needs to enact relief for tenants and landlords, as well as reinstate weekly supplements to unemployment benefits to help people stay current on rent.

Japan Society Presents When Practice Becomes Form: Carpentry Tools from Japan

Installation view at the Takenaka Carpentry Tools Museum, Kobe, Japan. On the occasion of the 50th anniversary of Japan Society’s landmark building, the institution is pleased to present the new exhibition, When Practice Becomes Form: Carpentry Tools from Japan. The exhibition celebrates the spirit of architecture and craftsmanship through Japanese woodworking tools as well as architectural patterns and various models. The site-specific installation, conceived by the esteemed contemporary architect Sou Fujimoto in collaboration with Brooklyn-based Popular Architecture, reinterprets major themes from the exhibition and is in dialogue with the gallery’s spaces, highlighting an enduring connection between traditional Japanese wooden construction and modern architecture. Featuring hand tools and joinery techniques that have been used for hundreds of years to build Japan’s wooden architectural masterpieces (from temples and shrines to teahouses and bridges), the exhibition unpacks how the intangible qualities of craftsmanship, such as consummate experience, knowledge, and the honed skills of master carpenters, have been transformed into significant forms of architecture. A diverse array of tools—planes, chisels, saws—have played an important role in the development of architecture in Japan’s history, and this philosophy extends to Japan’s cultural heritage today. Integral to the process of making by master carpenters (tōryo) is their extensive knowledge of the local environment and of wood as a material. Using natural resources and learning from their predecessors’ practices, they construct buildings using a refined methodology. Their philosophy of sustainability—for example, joinery can be restored or repaired as needed by future craftspeople—has been handed down over generations. Themes emerging from the exhibition have been interpreted by the internationally acclaimed architect Sou Fujimoto. His firm, Sou Fujimoto Architects, is based in Paris and Tokyo, and has been selected as site design producer for the 2025 World Exposition in Osaka, Japan. Fujimoto has designed the Serpentine Gallery pavilion in London (2013) among other internationally recognized projects. For this exhibition, Fujimoto has worked with Popular Architecture to explore the coexistence of nature and architecture. “Japan Society has been a home of cultural exchange, and a meeting place of past and present. In this exhibition, traditional Japanese craftsmanship is revealed in a new light by the design of contemporary architect Sou Fujimoto, and it becomes a precious educational opportunity to learn from this history,” says Yukie Kamiya, Japan Society Gallery Director. The building of Japan Society’s headquarters, designed by the architect Junzo Yoshimura (1908–1997), a major figure in 20th century Japanese architecture, opened to the public in 1971, becoming New York City’s first permanent structure designed by a Japanese citizen. It will commemorate its 50th anniversary in 2021. The building resides on land donated by John D. Rockefeller 3rd (1906–1978), former President and Chairman of Japan Society, who sought to revitalize the organization’s activities after World War II. Rockefeller 3rd and Yoshimura first met in Japan in 1951, and their friendship for over two decades resulted in Japan Society’s current building in Manhattan. Since its opening, the building has continued to serve as the central platform for the interexchange of ideas, knowledge, and innovation between the U.S. and Japan within a global context. In 2011, the building was designated landmark status by the New York City Landmarks Preservation Commission. When Practice Becomes Form: Carpentry Tools from Japan explores the connections between techniques, tools, and forms from traditional practices in Japanese carpentry and contemporary design perspectives. Paying homage to Japan Society’s building, where the arts and cultures of Japan and the United States intersect, this exhibition delves into the artistry and craftsmanship of architectural practice. Complementing the exhibition is a series of related public programs, including lectures, a hands-on workshop, and gallery tours. A digital publication illustrated and designed by Nathan Antolik further expands upon the exhibition. This exhibition is organized by Japan Society in collaboration with Takenaka Carpentry Tools Museum, Japan. The exhibition design is by Sou Fujimoto, in collaboration with Popular Architecture as local architect. About Sou Fujimoto Born in Hokkaido in 1971, Sou Fujimoto graduated from the Department of Architecture, Faculty of Engineering at Tokyo University and established Sou Fujimoto Architects in 2000. He has won several international competitions, including his recent 1st prize for the 2014 International Competition for the Second Folly of Montpellier, France ("L'Arbre Blanc"). In 2019, he was selected as the master architect for the Tsuda University Kodaira Campus Master Plan development. Among his notable projects are the annual summer pavilion for the Serpentine Gallery in London (2013)—the youngest architect to receive the commission; House NA in Tokyo (2012); Musashino Art University Museum & Library (2010); and House N (2008). In 2012, he was part of the Japanese team that won a Golden Lion award for Best National Participation at the Venice Architecture Biennale for their design of alternative housing concepts for homes destroyed by the 2011 tsunami. Most recently, he was selected as site producer for the 2025 World Exposition in Osaka, Japan. About Popular Architecture Brooklyn-based Popular Architecture combines simplicity with innovation across multiple scales ranging from master plans to buildings, interiors, and products. The firm is directed by Casey Mack, RA, LEED AP. After completing his M.Arch at Columbia, Mack worked with the Office for Metropolitan Architecture in Hong Kong and New York. He has taught urban design at the New York Institute of Technology and Passivhaus housing at Parsons School of Constructed Environments. Currently, with the support of the Graham Foundation for Advanced Studies in the Fine Arts, he is writing the book Digesting Metabolism: Artificial Land in Japan 1954-2202 (Hatje Cantz Verlag, 2021).

Examining the Popularity of the Bernie Sanders Meme

The image is a familiar one to millions across the country: Senator Bernie Sanders sitting with his legs crossed and arms across his chest—wearing a face mask, warm coat and knitted mittens—and watching as Joe Biden was sworn in as the 46th president of the United States on January 20, 2021. Two weeks later, however, the photo looks different. That's because very quickly that inauguration snapshot became an internet sensation, with people photoshopping it to create social media memes—placing Senator Sanders in famous paintings or scenes in movies ranging from the Breakfast Club to Star Trek. But what it is that draws people to these scenes and motivates them to create memes? Charles L. Folk, PhD, a professor of psychological and brain sciences at Villanova University, discusses the psychology behind it all. “Scenes and people activate ‘schemas’ in our memory,” says Dr. Folk. “Schemas are organized structures of knowledge, stored in memory, that are built up through experience. For example, we all have a ‘restaurant’ schema that stores information about the things that are typically in restaurants and the kinds of interactions we can expect in a restaurant.” Research suggests that our attention is drawn to objects that are incongruous with the “context” of a scene, Dr. Folk notes. “Thus, if we see a bedroom scene, our bedroom schema is activated, and our attention would be drawn to an object that is incongruent with that schema—like a toaster in a bedroom scene.” Dr. Folk shares that we have schemas for people as well. “Seeing Bernie Sanders activates our Bernie schema,” he says. “Bernie, in particular, has a very unique schema—so just seeing the picture of Bernie with his Vermont mittens is interesting/humorous because it is quite consistent with our schema of him.” “However, activating our Bernie schema in the context of an incongruent scene schema—like Bernie sitting on the bridge of the Starship Enterprise or a well-known movie set/scene—is particularly alluring precisely because of that incongruity,” continues Dr. Folk. Dr. Folk notes that the development of the app that can place the Bernie meme anywhere in Google Maps motivates people further to create their own versions of outrageous incongruity. “This contributes to the viral nature of the meme,” Dr. Folk says.

Network Science Offers Key Insights into Polarization, Disinformation, and Minority Power

People tend to think of the arena of politics as being driven by human decision and emotions, and therefore unpredictable. But network scientists like Boleslaw Szymanski, a computer science professor at Rensselaer Polytechnic Institute, have found that the country’s political activity – from American society’s ever-growing partisan divide to its grappling with the spread of misinformation online – can be explained by abstract and elegant models. These models provide insights — and even answers — to a number of pressing questions: Is increasing access to information driving us apart? Can an entrenched minority ultimately prevail? Could structural changes be made that insulate us from misinformation and reduce the polarization that divides us? Szymanski studies the technical underpinnings of our choices, how we influence one another, and the impact of the algorithms we rely upon to navigate a growing ocean of information. His work has yielded fascinating insights, including research on how a committed minority will overcome less determined opposition and the development of a parameter to determine what drives polarization in Congress. Through his research on the influence of minority opinions, Szymanski found that when just 10 percent of the population holds an unshakable belief, it will ultimately be adopted by the majority of the society. “When the number of committed opinion holders is below 10 percent, there is no visible progress in the spread of ideas. It would literally take the amount of time comparable to the age of the universe for this size group to reach the majority,” said Szymanski, a computer science professor at Rensselaer Polytechnic Institute. “Once that number grows above 10 percent, the idea spreads like flame.” In his present work, Szymanski is researching tools for measuring the level of polarization in specific news sites, search engines, and social media services, and developing remedies, like algorithms that offer better data provenance, detect misinformation, and create internal consistency reasoning, background consistency reasoning, and intra-element consistency reasoning tools. “Informed citizens are the foundation of democracy, but the driving interest of big companies that supply information is to sell us a product,” Szymanski said. “The way they do that on the internet is to repeat what we showed interest in. They’re not interested in a reader’s growth — they’re interested in the reader’s continued attention.” With the political environment becoming increasingly bitter and dubious information becoming ever more prevalent, Szymanski is available to discuss his research on polarization, disinformation, and the power of a committed minority.

UConn’s Dr. David Banach was one of the first to be vaccinated – let him explain the COVID-19 Vaccine

The initial doses of the first approved COVID-19 vaccine are here, and health care workers are part of the group that’s getting it first. One of them is Dr. David Banach, UConn Health infectious diseases physician and hospital epidemiologist, who sees the vaccine not only as a major breakthrough in the fight to end the pandemic, but also as an opportunity for his clinical colleagues to lead that effort and set the tone for the rest of the world. Here are some key facts about the COVID-19 vaccine, with Dr. Banach providing explanations of each: The COVID-19 vaccine won’t infect you with COVID-19. “There is no live virus in this vaccine, so you can’t actually get infected with SARS-CoV-2 from the vaccine. What this vaccine has is messenger RNA, which is a little bit of genetic code that allows the body’s natural machinery to make the protein that will generate an immune response." You may actually want some side effects from the COVID-19 vaccine. “You might get some soreness at the injection site, maybe some fatigue for a day or two, but that can be a good thing, a sign your body is making that immune response. That’s what is going to protect you in the future if you get exposed to the virus. The data from the clinical trials show the side effects – the soreness, fatigue, in some cases a short-lived fever – occur the first few days afterwards, and the rate of serious side effects is extraordinarily low for this vaccine.” The vaccine was developed relatively quickly, but not by compromising the scientific process. “When you look at Operation Warp Speed and how this process moved really quickly, that was really focused on the research and development piece and the manufacturing piece. Importantly, the phase 3 clinical trial was not rushed. This is the same type of clinical trial that we would do for any other vaccine. We followed people for at least two months. The clinical trials were huge, and they had diverse populations. So that part of the whole process wasn’t rushed at all, and that’s the most important part.” Don’t throw out those masks just yet. “We know this vaccine prevents people from developing symptomatic and severe COVID infection. I think what we don’t know is the effect it’s going to have on viral transmission, including asymptomatic shedding of virus. For instance, people who get the vaccine might still potentially shed virus, potentially at a lower level. The vaccine will prevent them from actually becoming ill, but vaccinated individuals might still be able to have virus in their nose and their respiratory system. Immunity from the vaccine is not instantaneous. “The COVID-19 vaccine clinical trials using the Pfizer-BioNTech and Moderna mRNA vaccines were designed using a two-dose series in order to generate the optimal level of protection from the vaccine. That’s why getting both doses of the vaccine is essential. Although there is likely some individual variability, immunity may not be optimal until several days after the second dose. The phase 3 clinical trials used a period of at least one-to-two weeks after the second dose as a marker of immunity during which they were able to demonstrate the efficacy of the vaccines in protecting against COVID-19 infection.” Dr. David Banach is one of the lead experts on COVID-19 in America. He is available to speak with media regarding the vaccination and what the future holds with regards to COVID-19. To book an interview – simply click on his icon and arrange a time now.

Georgia Southern's Continuing Education offers credentialing assistance to active-duty military

Active-duty soldiers and National Guard Reserve service members can take advantage of the certification programs offered through Georgia Southern University’s Division of Continuing Education, which is now an approved provider for the Army Credentialing Assistance (CA) program. Together with the Federal Tuition Assistance and Army Credentialing Assistance programs, soldiers can receive up to $4,000 total per fiscal year to cover costs for eligible certifications. The CA can cover the cost of training, materials, study guides, fees, textbooks and certification exams. Georgia Southern is one of the first universities approved in the country, and one of only a handful in Georgia, said Deedee Southerlin, Ed.D., manager of adult programs for Continuing Education. “This program is truly designed to enhance a soldier’s skill set for their current Military Occupational Specialty (MOS) and close the gap between relevant MOS’s and civilian certifications,” she said, noting these types of programs aren’t considered for academic credit, but rather nationally recognized certifications. “If a soldier chooses their certifications for a career post-military, it may help them secure employment quicker,” she added. “Many times when exiting the military, soldiers are really only trained on what their Army role was. These certifications can help them have more of a seamless transition into civilian life.” So far, Southerlin said these programs, which are completely online or virtual, have drawn participants from Georgia, Alaska, Korea, Maryland, Texas and Ohio, among others. In addition, spouses of service members on active-duty may take advantage of the workforce development program, My Career Advancement Account Scholarship (MyCAA), credentialing program as well. If you are a journalist looking to cover how schools like Georgia Southern University are supporting America’s military during and after they have served their duty –simply reach out to Georgia Southern Director of Communications Jennifer Wise at jwise@georgiasouthern.edu to arrange an interview today.